Hidenori Mizugaki
4PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 20, 2024
Real-world first-line treatment with pembrolizumab for non-small cell lung carcinoma with high PD-L1 expression: Updated analysis.Yasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki
|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata
|Jan 30, 2024
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101).Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo
|Apr 04, 2022
Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression.Yasuyuki Ikezawa, Hidenori Mizugaki, Ryo Morita
Pageof 1
Frequent Collaborators
2 joint publications
Megumi Furuta
1 joint publications
Nozomu Kimura
1 joint publications
Toshiyuki Sumi
1 joint publications
Shigehiro Yagishita
1 joint publications
Yuta Yamanaka
1 joint publications
Takayasu Kurata
1 joint publications
Kageaki Watanabe
1 joint publications
Yukio Hosomi
1 joint publications
Hidehito Horinouchi
1 joint publications
Yuichiro Ohe
